Insider · CIK 0001553333

Hoey Timothy

Reports to the SEC for 2 companies · REDWOOD CITY, CA

sec.gov

Transactions

Companies

Filings

CIK

0001553333

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-03-05	TNYATenaya Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−3,300 sh	$7.00	−$23.1K	245,346
2024-02-23	TNYATenaya Therapeutics, Inc.A Award	Chief Scientific Officer	AAward	+12.5K sh	—	—	248,646
2024-02-23	TNYATenaya Therapeutics, Inc. · Stock Option (Right to buy)A Award	Chief Scientific Officer	AAward	+75K sh	—	—	75,000
2024-02-20	TNYATenaya Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−6,369 sh	$5.31	−$33.8K	236,346
2024-02-20	TNYATenaya Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−200 sh	$6.17	−$1,233	236,146
2024-02-16	TNYATenaya Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−4,681 sh	$5.86	−$27.4K	242,715
2023-08-29	TNYATenaya Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−7,243 sh	$4.26	−$30.9K	247,396
2023-08-16	TNYATenaya Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−4,007 sh	$3.81	−$15.3K	254,639
2023-02-15	TNYATenaya Therapeutics, Inc.A Award	Chief Scientific Officer	AAward	+30K sh	—	—	228,646
2023-02-15	TNYATenaya Therapeutics, Inc.A Award	Chief Scientific Officer	AAward	+30K sh	—	—	258,646
2023-02-15	TNYATenaya Therapeutics, Inc. · Stock Option (Right to buy)A Award	Chief Scientific Officer	AAward	+175K sh	—	—	175,000
2022-04-26	TNYATenaya Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−1,353 sh	$10.13	−$13.7K	198,646
2022-02-15	TNYATenaya Therapeutics, Inc. · Stock Option (Right to buy)A Award	Chief Scientific Officer	AAward	+168K sh	—	—	168,000
2017-04-23	OncoMed Pharmaceuticals IncA Award	SVP, Cancer Biology & Co-CSO	AAward	+20K sh	—	—	77,225
2017-04-23	OncoMed Pharmaceuticals IncStock Option (Right to Buy)A Award	SVP, Cancer Biology & Co-CSO	AAward	+60K sh	—	—	60,000
2017-04-04	OncoMed Pharmaceuticals IncS Sale	SVP, Cancer Biology & Co-CSO	SSale	−43 sh	$8.87	−$381.285	62,936
2017-04-04	OncoMed Pharmaceuticals IncS Sale	SVP, Cancer Biology & Co-CSO	SSale	−5,711 sh	$9.06	−$51.7K	57,225
2017-01-03	OncoMed Pharmaceuticals IncM Exercise/Conversion	SVP, Cancer Biology & Co-CSO	MExercise/Conversion	+12.8K sh	$1.43	+$18.3K	73,742
2017-01-03	OncoMed Pharmaceuticals IncS Sale	SVP, Cancer Biology & Co-CSO	SSale	−12.8K sh	$7.64	−$97.4K	60,979
2017-01-03	OncoMed Pharmaceuticals IncStock Option (Right to Buy)M Exercise/Conversion	SVP, Cancer Biology & Co-CSO	MExercise/Conversion	−12.8K sh	—	—	0
2017-01-03	OncoMed Pharmaceuticals IncStock Option (Right to Buy)A Award	SVP, Cancer Biology & Co-CSO	AAward	+55K sh	—	—	55,000
2016-11-16	OncoMed Pharmaceuticals IncM Exercise/Conversion	SVP, Cancer Biology & Co-CSO	MExercise/Conversion	+12.5K sh	$1.43	+$17.9K	73,479
2016-11-16	OncoMed Pharmaceuticals IncS Sale	SVP, Cancer Biology & Co-CSO	SSale	−12.5K sh	$9.89	−$124K	60,979
2016-11-16	OncoMed Pharmaceuticals IncStock Option (Right to Buy)M Exercise/Conversion	SVP, Cancer Biology & Co-CSO	MExercise/Conversion	−12.5K sh	—	—	12,763
2016-10-09	OncoMed Pharmaceuticals IncA Award	SVP, Cancer Biology & Co-CSO	AAward	+12.5K sh	—	—	60,979
2016-01-07	OncoMed Pharmaceuticals IncS Sale	SVP, Cancer Biology & Co-CSO	SSale	−1 sh	$21.33	−$21.33	47,181
2016-01-06	OncoMed Pharmaceuticals IncS Sale	SVP, Cancer Biology & Co-CSO	SSale	−2,092 sh	$22.30	−$46.7K	47,251
2016-01-06	OncoMed Pharmaceuticals IncS Sale	SVP, Cancer Biology & Co-CSO	SSale	−69 sh	$21.56	−$1,487.647	47,182
2015-12-27	OncoMed Pharmaceuticals IncStock Option (Right to Buy)A Award	SVP, Cancer Biology & Co-CSO	AAward	+40K sh	—	—	40,000
2015-06-22	OncoMed Pharmaceuticals IncM Exercise/Conversion	SVP, Cancer Biology & Co-CSO	MExercise/Conversion	+5,000 sh	$1.43	+$7,150	54,343
2015-06-22	OncoMed Pharmaceuticals IncS Sale	SVP, Cancer Biology & Co-CSO	SSale	−5,000 sh	$26.07	−$130K	49,343
2015-06-22	OncoMed Pharmaceuticals IncStock Option (Right to Buy)M Exercise/Conversion	SVP, Cancer Biology & Co-CSO	MExercise/Conversion	−5,000 sh	—	—	25,263
2015-04-27	OncoMed Pharmaceuticals IncM Exercise/Conversion	SVP, Cancer Biology & Co-CSO	MExercise/Conversion	+5,000 sh	$1.43	+$7,150	56,230
2015-04-27	OncoMed Pharmaceuticals IncS Sale	SVP, Cancer Biology & Co-CSO	SSale	−3,537 sh	$25.12	−$88.9K	52,693
2015-04-27	OncoMed Pharmaceuticals IncS Sale	SVP, Cancer Biology & Co-CSO	SSale	−3,350 sh	$26.20	−$87.8K	49,343
2015-04-27	OncoMed Pharmaceuticals IncStock Option (Right to Buy)M Exercise/Conversion	SVP, Cancer Biology & Co-CSO	MExercise/Conversion	−5,000 sh	—	—	30,263
2015-02-05	OncoMed Pharmaceuticals IncM Exercise/Conversion	SVP, Cancer Biology & Co-CSO	MExercise/Conversion	+7,500 sh	$1.43	+$10.7K	57,445
2015-02-05	OncoMed Pharmaceuticals IncS Sale	SVP, Cancer Biology & Co-CSO	SSale	−7,500 sh	$22.83	−$171K	49,945
2015-02-05	OncoMed Pharmaceuticals IncStock Option (Right to Buy)M Exercise/Conversion	SVP, Cancer Biology & Co-CSO	MExercise/Conversion	−7,500 sh	—	—	35,263
2014-12-18	OncoMed Pharmaceuticals IncStock Option (Right to Buy)A Award	SVP, Cancer Biology & Co-CSO	AAward	+50K sh	—	—	50,000
2014-11-05	OncoMed Pharmaceuticals IncM Exercise/Conversion	SVP, Cancer Biology & Co-CSO	MExercise/Conversion	+2,500 sh	$1.43	+$3,575	52,445
2014-11-05	OncoMed Pharmaceuticals IncS Sale	SVP, Cancer Biology & Co-CSO	SSale	−2,500 sh	$19.51	−$48.8K	49,945
2014-11-05	OncoMed Pharmaceuticals IncStock Option (Right to Buy)M Exercise/Conversion	SVP, Cancer Biology & Co-CSO	MExercise/Conversion	−2,500 sh	—	—	42,763
2014-08-05	OncoMed Pharmaceuticals IncM Exercise/Conversion	SVP, Cancer Biology & Co-CSO	MExercise/Conversion	+2,500 sh	$1.43	+$3,575	51,843
2014-08-05	OncoMed Pharmaceuticals IncS Sale	SVP, Cancer Biology & Co-CSO	SSale	−2,300 sh	$21.61	−$49.7K	49,543
2014-08-05	OncoMed Pharmaceuticals IncS Sale	SVP, Cancer Biology & Co-CSO	SSale	−200 sh	$22.30	−$4,459	49,343
2014-08-05	OncoMed Pharmaceuticals IncStock Option (Right to Buy)M Exercise/Conversion	SVP, Cancer Biology & Co-CSO	MExercise/Conversion	−2,500 sh	—	—	45,263
2014-03-25	OncoMed Pharmaceuticals IncA Award	SVP, Cancer Biology & Co-CSO	AAward	+20K sh	—	—	49,343
2014-03-05	OncoMed Pharmaceuticals IncS Sale	SVP, Cancer Biology & Co-CSO	SSale	−1,792 sh	$35.81	−$64.2K	29,343
2014-02-05	OncoMed Pharmaceuticals IncM Exercise/Conversion	SVP, Cancer Biology & Co-CSO	MExercise/Conversion	+5,000 sh	$1.43	+$7,150	34,343

Recent filings

Accepted (ET)
Mar 64
Hoey Timothy0000950170-24-027442
SEC(opens sec.gov)
Feb 274
Hoey Timothy0000950170-24-021550
SEC(opens sec.gov)
Feb 214
Hoey Timothy0000950170-24-018222
SEC(opens sec.gov)
Feb 164
Hoey Timothy0000950170-24-016673
SEC(opens sec.gov)
Aug 294
Hoey Timothy0001209191-23-047673
SEC(opens sec.gov)
Aug 184
Hoey Timothy0001209191-23-046642
SEC(opens sec.gov)
Feb 174
Hoey Timothy0001209191-23-010887
SEC(opens sec.gov)
Apr 284
Hoey Timothy0001209191-22-026097
SEC(opens sec.gov)
Feb 174
Hoey Timothy0001209191-22-010916
SEC(opens sec.gov)
Apr 254
OncoMed Pharmaceuticals Inc0001140361-17-016768
SEC(opens sec.gov)
Apr 54
OncoMed Pharmaceuticals Inc0001140361-17-015047
SEC(opens sec.gov)
Jan 54
OncoMed Pharmaceuticals Inc0001140361-17-000848
SEC(opens sec.gov)

Companies

Address

C/O ONCOMED PHARMACEUTICALS, INC. 800 CHESAPEAKE DRIVE

REDWOOD CITY, CA, 94063